Skip to main content
New Microbes and New Infections logoLink to New Microbes and New Infections
. 2018 Jun 21;26:73–88. doi: 10.1016/j.nmni.2018.06.006

Noncontiguous finished genome sequences and description of Bacteroides mediterraneensis sp. nov., Bacteroides ihuae sp. nov., Bacteroides togonis sp. nov., Bacteroides ndongoniae sp. nov., Bacteroides ilei sp. nov. and Bacteroides congonensis sp. nov. identified by culturomics

C Andrieu 1,6, M Mailhe 1,6, D Ricaboni 1,4, MDM Fonkou 1, M Bilen 1, F Cadoret 1, E Tomei 2, N Armstrong 1, V Vitton 3, A Benezech 3, B Davoust 1, A Levasseur 1, J-C Lagier 1, P-E Fournier 2, D Raoult 1,5,
PMCID: PMC6154776  PMID: 30258636

Abstract

Culturomics is a concept developing different culture conditions in order to enlarge our knowledge of the human microbiota through the discovery of previously uncultured bacteria. This enabled us to isolate six new species of the Bacteroides genus: Bacteroides mediterraneensis strain Marseille-P2644, Bacteroides ihuae strain Marseille-P2824, Bacteroides togonis strain Marseille-P3166, Bacteroides ndongoniae strain Marseille-P3108, Bacteroides ilei strain Marseille-P3208 and Bacteroides congonensis strain Marseille-P3132. Those bacteria are Gram-negative anaerobic bacilli. We describe here their phenotypic features, together with phylogenetic analysis, matrix-assisted laser desorption/ionization time-of-flight mass spectrometry spectrum, fatty acid composition, and genome sequencing and annotation.

Keywords: Bacteroides species, culturomics, emerging bacteria, human microbiota, taxonogenomics

Introduction

The Bacteroides genus was discovered in 1919 and defined as the type genus of the Bacteroidaceae family [1]. The first type species, Bacteroides fragilis, was discovered in 1898 and approved in 1980 [2]. This genus currently comprises 52 validated species (http://www.bacterio.net/) (Fig. 1) including Bacteroides fragilis and Bacteroides thetaiotaomicron, the oldest and most studied species. Bacteria of this genus are nonsporulating, anaerobic, Gram negative and rod shaped [3]. Bacteroides is one of the major lineages present in the human colon and is involved in ‘good’ processes (production of energy source, activation of immune response) as well as ‘bad’ processes leading to diseases (abscess, reservoir of antibiotic resistance determinants, bacteraemia) [3]. More recent studies have attempted to elucidate the implication of those bacteria in colorectal cancer [4], [5].

Fig. 1.

Fig. 1

Identification of Bacteroides new species since first one, Bacteroides fragilis, was described by Veillon and Zuber in 1898 [2].

Consequently, enlarging our knowledge of bacteria that colonize the human gut, but more generally of the human microbiota, is foundational to better understand the multiple functions in which they are involved and enable the treatment of diseases. This is the reason why we used the culturomics concept, consisting of the use of multiple growth conditions, in order to identify new bacteria previously uncultivable with classic methods [6], [7], [8], [9]. This enabled us to isolate six new species of the Bacteroides genus. We used a taxonogenomics approach, including matrix-assisted desorption ionization–time of flight mass spectrometry (MALDI-TOF MS) spectrum, phylogenetic analysis, main phenotypic description and genome sequencing [10], [11], to describe the following bacteria: Bacteroides mediterraneensis strain Marseille-P2644 (= CSUR P2644 = DSM 103033), Bacteroides ihuae strain Marseille-P2824 (= CSUR P2824 = CCUG 70550), Bacteroides togonis strain Marseille-P3166 (= CSUR P3166 = DSM 103637), Bacteroides ndongoniae strain Marseille-P3108 (= CSUR P3108 = DSM 103636), Bacteroides ilei strain Marseille-P3208 (= CSUR P3208 = CCUG 69964) and Bacteroides congonensis strain Marseille-P3132 (= CSUR P3132 = CCUG 70144).

Materials and methods

Strain identification by MALDI-TOF MS and 16S rRNA gene sequencing

According to the culturomics approach, we tested 18 conditions on samples to isolate these strains, as previously described [7], [8]. The samples' origins and conditions of isolation are summarized in Table 1.

Table 1.

Sample information of six Bacteroides species

Characteristic B. ilei B. mediterraneensis B. ndongoniae B. togonis B. congonensis B. ihuae
Strain Marseille-P3208 Marseille-P2644 Marseille-P3108 Marseille-P3166 Marseille-P3132 Marseille-P2824
Sample origin Human ileum Human ileum Human right colon Human right colon Human stool Human sputum
Patient information 76-year-old woman with oesophagitis (Marseille, France), no antibiotics 58-year-old woman realizing colorectal cancer screening (Marseille, France), no antibiotics 76-year-old woman with oesophagitis (Marseille, France), no antibiotics 76-year-old woman with oesophagitis (Marseille, France), no antibiotics 35-year-old healthy Pygmy woman (Congo), no treatment Healthy 27-year-old woman (Marseille, France), no treatment
Authorization/consent Committee of ‘IHU Méditerranée Infection,’ No. 2016-010, signed consent Committee of ‘IHU Méditerranée Infection,’ No. 2016-010, signed consent Committee of ‘IHU Méditerranée Infection,’ No. 2016-010, signed consent Committee of ‘IHU Méditerranée Infection,’ No. 2016-010, signed consent Committee of ‘IHU Méditerranée Infection,’ No. 2016-011, signed consent Committee of ‘IHU Méditerranée Infection,’ No. 2016-011, signed consent
Storage No storage, fresh sample No storage, fresh sample No storage, fresh sample No storage, fresh sample +4°C No storage, fresh sample
Isolation conditions 7 days on COS, 37°C, anaerobic 1 day on COS, 37°C, anaerobic 7 days on COS, 37°C, anaerobic 3 days on COS, 37°C, anaerobic Blood culture (+5% sheep's blood + 5% rumen) + 10 days on COS, 37°C, anaerobic Blood culture (+5% rumen) + 10 days on COS, 30°C, anaerobic

COS, Columbia medium supplemented with 5% sheep's blood.

Purified colonies were identified by MALDI-TOF MS using a Microflex LT spectrometer and an MSP 96 MALDI-TOF target plate (Bruker Daltonics, Bremen, Germany), as previously described [12], [13]. The obtained spectra were imported into MALDI Biotyper 3.0 software (Bruker Daltonics) and analysed by standard pattern matching (with default parameter settings) against the main spectra of the 7537 bacteria included in the databases (Bruker and constantly updated Microbes Evolution Phylogeny and Infections (MEPHI) databases). The resulting score enabled the identification (or not) of tested species: a score of ≥2 with a validly published species enabled identification at the species level, a score of ≥1.7 but <2 enabled identification at the genus level and a score of <1.7 did not enable any identification. No significant scores were obtained for the studied strains, suggesting that our isolates were not members of known species.

Consequently, sequencing of the 16S rRNA gene was performed in order to identify these strains. DNA was previously extracted by EZ1 DNA Tissue Kit using BioRobot EZ1 Advanced XL (Qiagen, Courtaboeuf, France). The amplification and purification of the 16S rRNA gene was performed as previously described [14], [15] by use of the universal primers pair fD1 and rP2 (Eurogentec, Angers, France). Sequencing was then done using the Big Dye Terminator v1.1 Cycle Sequencing Kit and ABI Prism 3130xl Genetic Analyzer capillary sequencer (Applied Biosystems; Thermo Fisher Scientific, Waltham, MA, USA), as previously described [14], [15]. The 16S rRNA nucleotide sequences were assembled and corrected using CodonCode Aligner software (http://www.codoncode.com), and BLASTn searches were performed against the National Center for Biotechnology Information (NCBI) GenBank database (http://blast.ncbi.nlm.nih.gov.gate1.inist.fr/Blast.cgi) to determine the percentage of similarity with the closest bacteria. A similarity threshold of <98.65% enabled us to define a new species, whereas a threshold of <95% enabled us to define a new genus without performing DNA-DNA hybridization [16].

Phylogenetic analysis

A custom Python script was used to automatically retrieve all species from the same family as that of the new species, and we downloaded 16S sequences from NCBI by parsing NCBI eUtils results and the NCBI taxonomy page. It only kept sequences from type strains. The script then divided 16S sequences into two groups: one containing the sequences of strains from the same genus (group A) and one containing the others (group B). Finally, it only kept the 49 closest strains from group A and one from group B (outgroup).

Phenotypic, biochemical and antibiotic susceptibility tests

Ideal growth conditions of the studied strains were determined by testing five growth temperatures (25, 30, 37, 42, 56°C) in an aerobic atmosphere with or without 5% CO2 and under anaerobic and microaerophilic conditions using the GENbag anaer and GENbag microaer systems, respectively (bioMérieux, Marcy l’Étoile, France). Different pH values (5, 5.5, 6, 6.5, 7, 7.5, 8, 8.5) and NaCl concentrations (5, 10, 50, 75, 100, 150, 200 g/L) were also tested. Phenotypic characteristics such as Gram staining, motility, sporulation, and catalase and oxidase activities were tested as previously described [7].

The biochemical analysis was carried out using API 50CH, API 20A, API ZYM strips (bioMérieux) in an anaerobic atmosphere, according to the manufacturer's instructions. Cellular fatty acid methyl ester (FAME) analysis was performed by gas chromatography/mass spectrometry (GC/MS). Two samples were prepared with approximately 20 to 70 mg (according to bacteria) of bacterial biomass per tube collected from several culture plates. FAME were prepared as described by Sasser [17]. GC/MS analyses were carried out as previously described [18]. Briefly, FAME were separated using an Elite 5-MS column and monitored by mass spectrometry (Clarus 500–SQ 8 S; Perkin Elmer, Courtaboeuf, France). A spectral database search was performed using MS Search 2.0 operated with the Standard Reference Database 1A (National Institute of Standards and Technology, Gaithersburg, MD, USA) and the FAMEs mass spectral database (Wiley, Chichester, UK). Antibiotic susceptibility was tested using the disc diffusion method [19] and according to European Committee on Antimicrobial Susceptibility Testing 2018 recommendations.

Microscopy

Negative staining was performed in order to observe the cells' morphology. The cells were fixed with 2.5% glutaraldehyde in 0.1 M cacodylate buffer for at least 1 hour at 4°C. A drop of cell suspension was deposited for approximately 5 minutes on glow-discharged Formvar carbon film with 400 mesh nickel grids (FCF400-Ni; Electron Microscopy Sciences (EMS), Hatfield, PA, USA). The grids were dried on blotting paper, and the cells were negatively stained for 10 seconds with 1% ammonium molybdate solution in filtered water at room temperature. Electron micrographs were acquired with a Tecnai G20 Cryo (FEI Company, Limeil-Brévannes, France) transmission electron microscope operated at 200 keV or with a Morgagni 268D (Philips, Amsterdam, The Netherlands) transmission electron microscope operated at 80 keV.

DNA extraction and genome sequencing

Genomic DNA (gDNA) of strains Marseille-P3132, Marseille-P3166 and Marseille-P3208 were first extracted by a mechanical treatment using acid-washed glass beads (G4649–500g; MilliporeSigma, St. Louis, MO, USA) and a FastPrep BIO 101 instrument (Qbiogene, Strasbourg, France) at maximum speed (6.5) for 3 × 30 seconds. Then for all the studied Bacteroides strains a 2-hour lysozyme incubation at 37°C was done and gDNA was extracted using the EZ1 biorobot (Qiagen) with the EZ1 DNA tissues kit. The elution volume was 50 μL. gDNA was quantified by a Qubit assay with the High Sensitivity kit (Life Technologies, Carlsbad, CA, USA) (Supplementary Table S1).

gDNA was sequenced on the MiSeq Technology (Illumina, San Diego, CA, USA) with the mate pair strategy. The gDNA was barcoded in order to be mixed with 11 other projects with the Nextera Mate Pair sample prep kit (Illumina). The mate pair library was prepared with 1.5 μg of gDNA using the Nextera mate pair Illumina guide. The gDNA sample was simultaneously fragmented and tagged with a mate pair junction adapter. The pattern of fragmentation was validated on an Agilent 2100 BioAnalyzer (Agilent Technologies, Santa Clara, CA, USA) with a DNA 7500 labchip. The DNA fragments ranged in size from 1.5 to 11 kb (with an optimal size at 7.710, 6.047, 7.937, 7.840, 10.380 and 6.752 kb for strain Marseille-P2644, Marseille-P2824, Marseille-P3132, Marseille-P3108, Marseille-P3166 and Marseille-P3208, respectively). No size selection was performed, and 600 ng (610.4 ng for strain Marseille-P3132 and 369.6 ng for strain Marseille-P3108) of tagmented fragments were circularized. The circularized DNA was mechanically sheared to small fragments (with an optimal size of 1209, 997, 1140 and 1167 bp for strain Marseille-P3132, Marseille-P3108, Marseille-P3166 and Marseille-P3208, with optima on a bimodal curve at 975 and 1514 bp for strain Marseille-P2824 and with optima on a trimodal curve at 675, 1252 and 2049 bp for strain Marseille-P2644) on the Covaris device S2 in T6 tubes (Covaris, Woburn, MA, USA). The library profile was visualized on a High Sensitivity Bioanalyzer LabChip (Agilent Technologies), and the final concentration library was measured (Supplementary Table S1).

The libraries were normalized at 2 nM and pooled. After a denaturation step and dilution at 15 pM, the pool of libraries was loaded onto the reagent cartridge and then onto the instrument along with the flow cell. Automated cluster generation and sequencing run were performed in a single 39-hour run in a 2 × 151 bp (2 × 251 bp for strains Marseille-P3108, Marseille-P3166 and Marseille-P3208). The paired reads were finally trimmed and assembled. Complementary information is available in Supplementary Table S1.

Genome assembly, annotation and comparison

The genomes' assembly was performed with a pipeline that enabled us to create an assembly with different software packages (Velvet [20], Spades [21] and Soap Denovo [22]), on trimmed (MiSeq and Trimmomatic [23] software) or untrimmed data (only MiSeq software). For each of the six assemblies performed, GapCloser [22] was used to reduce gaps. Then contamination with Phage Phix was identified (BLASTn against Phage Phix174 DNA sequence) and eliminated. Finally, scaffolds under 800 bp in size were removed and scaffolds with a depth value lower than 25% of the mean depth were removed (identified as possible contaminants). The best assembly was selected by using different criteria (number of scaffolds, N50, number of N). For all studied strains, Spades gave the best assembly (with a depth coverage of 153, 44, 647, 99 and 94, respectively, for strains Marseille-P2824, Marseille-P3132, Marseille-P3108, Marseille-P3166 and Marseille-P3208), except for strain Marseille-P2644, which obtained the best assembly with Velvet (with a depth coverage of 174).

Open reading frames (ORFs) were predicted using Prodigal [24] with default parameters, but the predicted ORFs were excluded if they spanned a sequencing gap region (contained N). The predicted bacterial protein sequences were searched against the Clusters of Orthologous Groups (COGs) database using BLASTP (E value of 1e-03, coverage 0.7 and identity percentage 30%). If no hit was found, we searched against the NR database using BLASTP (E value of 1e-03, coverage 0.7 and identity percent of 30%). If the sequence length was smaller than 80 aa, we used an E value of 1e-05. The tRNAScanSE [25] tool was used to find transfer RNA genes, whereas ribosomal RNA genes were found by using RNAmmer [26]. Lipoprotein signal peptides and the number of transmembrane helices were predicted using Phobius [27]. ORFans were identified if all the BLASTP searches we performed failed to provide positive results (E value smaller than 1e-03 for ORFs with sequence size superior to 80 aa or E value smaller than 1e-05 for ORFs with sequence length smaller than 80 aa). Such parameter thresholds have already been used in previous works to define ORFans. Pfam-conserved domains (Pfam-A and Pfam-B domains) were searched on each protein with an HMMscan of the HMMER3 suite [28]. Number of genes associated to polyketide synthase (PKS) or nonribosomal peptide synthase (NRPS) and antibiotic resistance genes were found using the BLAST program against the ClusterMine360 specific database [29] and the Homemade database [30], respectively. The annotation process was performed in the multi-agent software system DAGOBAH [31], which includes Figenix [32] libraries, which provided the pipeline analysis.

Species that must be compared were automatically retrieved from the 16S RNA tree using PhyloPattern. For each selected species, the complete genome sequence, proteome sequence and ORFeome sequence were retrieved from the NCBI's FTP site. If one specific strain did not have a complete and available genome, a complete genome of the same species was used. If ORFeome and proteome were not predicted, Prodigal was used with default parameters to predict them. All proteomes were analysed with proteinOrtho [33]. Then, for each couple of genomes, a similarity score was computed. This score is the mean value of nucleotide similarity between all couples of orthologous genes between the two genomes studied (average genomic identity of orthologous gene sequences (AGIOS) tool). An annotation of all proteomes was also realized to define the distribution of functional classes of predicted genes according to the clusters of orthologous groups of proteins (with same method as that used for genome annotation). The comparison process was performed in DAGOBAH [31], which includes Figenix [32] libraries, which provided pipeline analysis, and by using PhyloPattern [34] for tree manipulation.

Results

Strain identification and phylogenetic analysis

The studied strains could not be identified using MALDI-TOF MS, and therefore their 16S rRNA gene was sequenced. Strain Marseille-P3132 (accession no. LT598566) revealed 96.74% sequence similarity with the 16S rRNA of Bacteroides thetaiotaomicron strain VPI-5482, the closest species with a validly published name. We consequently propose that our strain is a representative strain of a new species within the Bacteroides genus for which we suggest the name ‘Bacteroides congonensis’ strain Marseille-P3132. Strain Marseille-P2824 (accession no. LT576386) revealed 95.62% sequence similarity with the 16S rRNA of Bacteroides graminisolvens strain JCM15093, the closest species with a validly published name. We consequently propose that our strain is a representative strain of a new species within the genus Bacteroides for which we suggest the name ‘Bacteroides ihuae’ strain Marseille-P2824. Strain Marseille-P3208 (accession no. LT623890) revealed 94.29% sequence similarity with the 16S rRNA of Bacteroides coprophilus strain CB42, the closest species with a validly published name. Although this value is under the threshold of 95%, we proposed this strain as a new species and not a new genus according to the low percentage of similarity already existing between two validly published Bacteroides species (74.8–98.7%) [35]. We consequently propose that our strain is a representative strain of a new species within the genus Bacteroides for which we suggest the name ‘Bacteroides ilei’ strain Marseille-P3208. Strain Marseille-P3108 (accession no. LT615364) revealed 93.91% sequence similarity with the 16S rRNA of Bacteroides eggerthii strain JCM12986, the closest species with a validly published name. We consequently propose that our strain is a representative strain of a new species within the genus Bacteroides for which we suggest the name ‘Bacteroides ndongoniae’ strain Marseille-P3108. Strain Marseille-P3166 (accession no. LT631521) revealed 93.14% sequence similarity with the 16S rRNA of Bacteroides eggerthii strain JCM12986, the closest species with a validly published name. We consequently propose that our strain is a representative strain of a new species within the genus Bacteroides for which we suggest the name ‘Bacteroides togonis’ strain Marseille-P3166. Strain Marseille-P2644 (accession no. LT558804) revealed a 94.61% sequence similarity with the 16S rRNA of Bacteroides coprocola strain M16, the closest species with a validly published name. We consequently propose that our strain is a representative strain of a new species within the genus Bacteroides for which we suggest the name ‘Bacteroides mediterraneensis’ strain Marseille-P2644.

A phylogenetic tree showing the position of the studied strains in the Bacteroides genus is shown in Fig. 2. We observed that B. ilei and B. mediterraneensis, which are closely related, exhibited a 95.31% similarity, which confirms that they belong to two distinct species. The same observation was made for B. ndongoniae and B. togonis, which exhibited a 93.05% 16S rRNA similarity. All spectra (Fig. 3(A)) were added to MEPHI database (http://www.mediterranee-infection.com/article.php?larub=280&titre=urms-database). A gel view was made in order to compare proteomic profiles between the studied strains and their closest species (Fig. 3(B)). The analysis revealed a common general profile between Bacteroides strains, including the studied strains, whereas the outsider species Parabacteroides goldsteinii profile shows several unique differences.

Fig. 2.

Fig. 2

Phylogenetic tree highlighting position of studied strains relative to other Bacteroides species. Respective GenBank accession numbers for 16S rRNA genes are indicated in parentheses. Sequences were aligned by Muscle v3.8.31 with default parameters and phylogenetic inferences were obtained using neighbour-joining method with 500 bootstrap replicates within MEGA6 software. Only bootstrap values > 95% are shown. Mangroviflexus xiamenensis was used as outgroup. Scale bar represents a 0.02% nucleotide sequence divergence.

Fig. 3.

Fig. 3

(A) Reference mass spectra. Spectra from 12 individual colonies were compared and each reference spectrum generated. (B) Gel view comparing studied strains to other species within Bacteroides genus. Gel view displays raw spectra of loaded spectrum files arranged in a pseudo-gel–like look. X-axis records m/z value. Left y-axis displays running spectrum number originating from subsequent spectra loading. peak intensity is expressed by greyscale scheme code. Colour bar and right y-axis indicate relation between colour and peak intensity in arbitrary units. Displayed species are indicated at left.

Phenotypic features

The main phenotypic results of each studied strain compared to published data of close species are presented in Table 2 [36], [37], [38]. The results show that the morphologic description, notably Gram staining, cell shape, spore formation and atmosphere, supports the fact that these six new species are members of the Bacteroides genus. These observations were confirmed by electronic microscopy (Fig. 4), which revealed a similar morphology. Regarding the biochemical characteristics, nearly all compared strains were negative for oxidase and urease activities and mannitol metabolism, whereas they were positive for β-galactosidase and alkaline phosphatase activities (Table 2). A more detailed analysis of biochemical features of the studied strains is available in Supplementary Tables S2, S3 and S4, corresponding to API strip results. Finally, we observed that the main fatty acid is C15:0 anteiso for nearly all compared strains (Table 2).

Table 2.

Comparison of phenotypic characteristics between nine Bacteroides species [36], [37], [38]

Property B. ilei B. mediterraneensis B. coprocola B. ndongoniae B. togonis B. finegoldii B. congonensis B. ihuae B. graminisolvens
Strain Marseille-P3208 Marseille-P2644 M16T Marseille-P3108 Marseille-P3166 199T Marseille-P3132 Marseille-P2824 XDT-1T
Optimal temperature 37°C 37°C 37°C 37°C 37°C 37°C 37°C 30°C 30–35°C
Atmosphere Anaerobic Anaerobic Anaerobic Anaerobic Anaerobic Anaerobic Anaerobic Anaerobic Anaerobic
pH range 5–7.5 5–8, NA 7–7.5 7–7.5 NA 6–8.5 6–8.5 6.1–8.2
Colony aspect Circular, translucent Circular, grey, translucent, shiny Disc shaped and greyish-white Circular, grey, translucent, small Small, circular and white Circular, translucent-whitish, raised, convex Smooth Mucous Thin, smooth-surfaced, with pearl-like, iridescent lustre
Cell shape Fusiform Rod Rod Rod Rod Rod Rod Rod Rod
Cell length (μm) 3.9–5 0.9–2.3 1–4, 2.2–3.1 1.4–3.2 1.5–4.5 2–2.1 1.2–1.8 1.2–4.5
Cell width (μm) 0.5–0.6 0.6–0.7 0.8 0.6–1.1 0.6–0.7 0.8 2–2.1 0.5–0.6 0.4–0.6
Gram staining Negative Negative Negative Negative Negative Negative Negative Negative Negative
Salt tolerance (g.L−1) 0 0 NA 0 0 NA 50 5 0–40
Motility + + + +
Endospore formation
Major cellular fatty acid 15:0 anteiso 15:0 anteiso 15:0 anteiso 16:0. 15:0 iso 15:0 anteiso 15:0 anteiso 15:0 anteiso 15:0 anteiso
Production of:
Alkaline phosphatase + + + + + + + + NA
Catalase + + NA +
Oxidase NA NA
Urease
β-Galactosidase + + + + + + + + NA
N-Acetyl-glucosamine + NA + NA + + NA
Acid from:
L-Arabinose + + + + +
Ribose NA NA + + w
Mannose + + + + +
Mannitol
d-Saccharose + + + + + +
d-Glucose + + + + + +
d-Fructose NA NA + + +
d-Maltose + + + + + +
d-Lactose + + + + +
Habitat Human ileum Human ileum Human stool Human right colon Human right colon Human faeces Human stool Human sputum Rice-straw residue

+, positive result; −, negative result; NA, data not available.

Fig. 4.

Fig. 4

Gram staining and electron micrographs of Bacteroides new species: B. ihuae (A, B), B. togonis (C, D), B. ndongoniae (E, F), B. mediterraneensis (G, H), B. ilei (I, J) and B. congonensis (K, L), respectively.

The composition in cellular fatty acids of the studied strains is presented in detail in Table 3; results of antibiotic susceptibility testing are presented in Table 4. We observed that the major cellular fatty acid of the studied Bacteroides strains is 12-methyl-tetradecanoic acid except for the Marseille-P3166 and Marseille-P3108 strains (Table 3). Table 4 shows that the strains often have the same antibiotic susceptibility profile, except strain Marseille-P3132. Nevertheless, all strains are susceptible to imipenem, amoxicillin, amoxicillin/clavulanic acid, metronidazole and rifampicin and resistant to gentamicin.

Table 3.

Cellular fatty acid composition (in %a) of five Bacteroides species

Fatty acid
IUPAC name B. ilei
B. mediterraneensis
B. ndongoniae
B. togonis
B. congonensis
B. ihuae
Strain Marseille-P3208 Marseille-P2644 Marseille-P3108 Marseille-P3166 Marseille-P3132 Marseille-P2824
5:0 iso 3-methyl-Butanoic acid No No No No 1.4 ± 0.3 TR
5:0 anteiso 2-methyl-Butanoic acid No 1.4 ± 0.2 No TR No No
13:0 iso 11-methyl-Dodecanoic acid TR No No No TR TR
13:0 anteiso 10-methyl-Dodecanoic acid TR No No No TR TR
14:0. Tetradecanoic acid 3.9 ± 0.2 1.2 ± 0.1 8.6 ± 0.2 4.7 ± 0.5 1.7 ± 0.1 1.4 ± 0.4
14:0 3-OH 3-hydroxy-Tetradecanoic acid TR No No No No No
14:0 iso 12-methyl-Tridecanoic acid 1.0 ± 0.1 No No No 1.8 ± 0.1 No
15:0. Pentadecanoic acid 1.5 ± 0.2 1.4 ± 0.2 2.1 ± 0.2 2.4 ± 0.1 1.2 ± 0.1 TR
15:0 iso 13-methyl-Tetradecanoic acid 23.2 ± 0.7 13.9 ± 0.8 12.9 ± 0.5 26.4 ± 0.3 13.8 ± 0.2 4.0 ± 0.3
15:0 anteiso 12-methyl-Tetradecanoic acid 46.6 ± 3.2 39.2 ± 0.2 17.6 ± 0.7 15.1 ± 0.4 59.5 ± 1.5 46.7 ± 3.3
15:0 3-OH 3-hydroxy-Pentadecanoic acid TR TR No TR TR TR
15:0 3-OH iso 3-hydroxy-13-methyl-Tetradecanoic acid 1.2 ± 0.2 1.7 ± 0.1 No TR TR TR
15:0 3-OH anteiso 3-hydroxy-12-methyl-Tetradecanoic acid TR TR No No No No
16:0. Hexadecanoic acid 8.3 ± 0.6 4.4 ± 0.1 26.3 ± 1.3 15.8 ± 0.5 4.3 ± 0.2 4.0 ± 0.1
16:0 3-OH 3-hydroxy-Hexadecanoic acid 1.1 ± 0.3 4.4 ± 0.1 4.2 ± 0.7 5.2 ± 0.3 3.9 ± 0.3 2.5 ± 0.1
16:0 3-OH iso 3-hydroxy-14-methyl-Pentadecanoic acid No TR No No TR TR
16:0 9,10-methylene 2-hexyl-Cyclopropaneoctanoic acid No No No No TR TR
17:0 Heptadecanoic acid No TR No TR No No
17:0 iso 15-methyl-Hexadecanoic acid No TR No 1.2 ± 0.1 No No
17:0 anteiso 14-methyl-Hexadecanoic acid No TR No TR No TR
17:1n7 iso 15-Methylhexadec-9-enoic acid No No No No No TR
17:0 3-OH iso 3-hydroxy-15-methyl-Hexadecanoic acid TR 16.3 ± 0.5 TR 6.6 ± 0.5 7.3 ± 0.4 17.8 ± 1.0
17:0 3-OH anteiso 3-hydroxy-14-methyl-Hexadecanoic acid TR 5.2 ± 0.8 TR TR 1.6 ± 0.1 12.8 ± 2.1
17:1n7 anteiso 14-Methylhexadec-9-enoic acid No No No No No TR
18:0. Octadecanoic acid 2.2 ± 0.4 2.0 ± 0.1 10.0 ± 0.4 6.8 ± 0.1 TR 1.4 ± 0.9
18:1n7 11-Octadecenoic acid No No No No No TR
18:1n9 9-Octadecenoic acid 4.9 ± 0.6 3.2 ± 0.2 11.3 ± 0.7 8.7 ± 0.5 1.0 ± 0.2 2.1 ± 0.2
18:2n6 9,12-Octadecadienoic acid 3.5 ± 0.5 2.5 ± 0.1 5.8 ± 0.5 4.6 ± 0.1 TR 2.7 ± 0.3
20:4n6 5,8,11,14-Eicosatetraenoic acid No TR No No No No
a

Mean peak area percentage ±standard deviation; TR, trace amounts <1%; no, not present.

Table 4.

Antibiotic resistance test results of six Bacteroides species

Antibiotic Disc load (μg/mL) B. ilei Marseille-P3208 B. mediterraneensis Marseille-P2644 B. ndongoniae Marseille-P3108 B. togonis Marseille-P3166 B. congonensis Marseille-P3132 B. ihuae Marseille-P2824
Amoxicillin 25 S S S S S S
Clindamycin 15 S S R R R S
Imipenem 10 S S S S S S
Gentamicin 15 R R R R R R
Amoxicillin/clavulanic acid 30 S S S S S S
Penicillin 10U S S S S NA S
Metronidazole 4 S S S S S S
Trimethoprim/sulfamethoxazole 25 S R R R S S
Oxacillin 5 S R R R R R
Tobramycin 10 S S S S R S
Ceftriaxone 30 S S S S R R
Rifampicin 30 S S S S S S
Doxycycline 30 S S S S NA S
Erythromycin 15 S R R R R S

NA, not available; R, resistant; S, susceptible.

Genome description and comparison

The genomes of the studied strains are represented in a map in Supplementary Fig. 1. The detail of the genomes' content and statistics are summarized in Table 5, and the distribution of predicted genes in COGs categories is shown in Table 6. We observed that the gene distribution in the 25 general COGs functional categories of the six new Bacteroides species is similar. The genomic characteristics of the studied strains were compared to the available genomes of closely related species in Table 7. This enabled us to observe that for all studied strains, the genome's size, percentage of G+C content and number of total genes are in the same range as those of other Bacteroides species.

Table 5.

Nucleotide content and gene count levels of genomes of six Bacteroides species

Attribute
B. ilei
B. mediterraneensis
B. ndongoniae
B. togonis
B. congonensis
B. ihuae
Scaffolds/contigs 14; 18
18; 24
14; 14
23; 30
11; 11
6; 6
Value % of totala Value % of totala Value % of totala Value % of totala Value % of totala Value % of totala
Size (bp) 3 974 619 100 4 075 657 100 4 949 270 100 3 977 096 100 6 373 337 100 4 063 701 100
G + C content (mol%) 1 789 237 45.02 1 933 958 47.47 2 359 608 47.67 1 918 144 48.25 2 738 514 42.96 1 613 861 39.71
Coding region (bp) 3 615 554 90.96 3 687 552 90.47 4 396 977 88.84 3 590 610 90.28 5 824 153 91.38 3 669 831 90.30
Total genes 3517 100 3515 100 4285 100 3487 100 5067 100 3396 100
Protein-coding genes 3425 97.38 3419 97.26 4205 98.13 3419 98.04 4988 98.44 3332 98.11
RNA genes 92
(7 5S, 3 16S, 3 23S rRNA, 79 tRNA)
2.61 96(6 5S, 3 16S, 1 23S rRNA, 86 tRNA) 2.73 80
(5 5S, 5 16S, 5 23S rRNA, 65 tRNA)
1.86 68
(4 5S, 1 16S, 1 23S rRNA, 62 tRNA)
1.95 79
(4 5S, 3 16S, 1 23S rRNA, 71 tRNA)
1.55 64
(4 5S, 1 16S, 1 23S rRNA, 58 tRNA)
1.88
Proteins with function prediction 2551 74.48 2814 82.30 3234 76.90 283 82.77 3815 76.48 2366 71.00
Proteins assigned to COGs 1636 47.76 1672 48.90 1796 42.71 1638 47.90 2211 44.32 1804 54.14
Proteins with peptide signals 842 24.58 907 26.52 1124 26.73 877 25.65 1701 34.10 978 29.35
No. of protein associated to ORFan 178 5.19 143 4.18 178 4.23 133 3.89 126 2.52 201 6.03
Genes with transmembrane helices 660 19.27 680 19.88 805 19.14 667 19.50 902 18.08 641 19.23
Genes associated with PKS or NRPS 10 0.29 8 0.23 9 0.21 9 0.26 9 0.18 6 0.18
No. of antibiotic resistance genes 0 0 2 0.05 4 0.09 3 0.08 1 0.02 0 0
No. of genes associated with Pfam-A domains 3018 85 3052 86 3654 85 2998 85 4494 88 3011 88

COGs, Clusters of Orthologous Groups database; NRPS, nonribosomal peptide synthase; PKS, polyketide synthase.

a

Total is based on either size of genome in base pairs or total number of protein-coding genes in annotated genome.

Table 6.

Number of genes associated with 25 general COGs functional categories for six Bacteroides species

Code Description B. ilei
B. mediterraneensis
B. ndongoniae
B. togonis
B. congonensis
B. ihuae
Value % of totala Value % of totala Value % of totala Value % of totala Value % of totala Value % of totala
J Translation 180 5.25 178 5.20 182 4.32 179 5.23 194 3.88 190 5.70
A RNA processing and modification 0 0 0 0 0 0 0 0 0 0 0 0
K Transcription 76 2.21 93 2.72 103 2.44 107 3.12 162 3.24 115 3.45
L Replication, recombination and repair 108 3.15 112 3.27 135 3.21 112 3.27 131 2.62 92 2.76
B Chromatin structure and dynamics 0 0 0 0 0 0 0 0 0 0 0 0
D Cell cycle control, mitosis and meiosis 26 0.75 23 0.67 29 0.68 27 0.78 25 0.50 25 0.75
Y Nuclear structure 0 0 0 0 0 0 0 0 0 0 0 0
V Defense mechanisms 70 2.04 83 2.42 101 2.40 86 2.51 88 1.76 83 2.49
T Signal transduction mechanisms 62 1.81 71 2.07 82 1.95 80 2.33 118 2.36 76 2.28
M Cell wall/membrane biogenesis 142 4.14 168 4.91 178 4.23 161 4.70 227 4.55 170 5.10
N Cell motility 11 0.32 11 0.32 15 0.35 11 0.32 20 0.40 14 0.42
Z Cytoskeleton 0 0 0 0 0 0 0 0 0 0 0 0
W Extracellular structures 0 0 0 0 0 0 0 0 0 0 0 0
U Intracellular trafficking and secretion 25 0.72 33 0.96 37 0.87 29 0.84 34 0.68 23 0.69
O Post-translational modification, protein turnover, chaperones 75 2.18 80 2.33 76 1.80 70 2.04 81 1.62 77 2.31
X Mobilome: prophages, transposons 47 1.37 14 0.40 35 0.83 21 0.61 51 1.02 16 0.48
C Energy production and conversion 112 3.27 112 3.27 105 2.49 99 2.89 125 2.50 114 3.42
G Carbohydrate transport and metabolism 162 4.72 156 4.56 176 4.18 154 4.50 257 5.15 190 5.70
E Amino acid transport and metabolism 134 3.91 132 3.86 128 3.04 118 3.45 164 3.28 149 4.47
F Nucleotide transport and metabolism 70 2.04 64 1.87 63 1.49 64 1.87 69 1.38 71 2.13
H Coenzyme transport and metabolism 109 3.18 121 3.53 103 2.44 97 2.83 114 2.28 116 3.48
I Lipid transport and metabolism 57 1.66 63 1.84 60 1.42 55 1.60 86 1.72 70 2.10
P Inorganic ion transport and metabolism 102 2.97 111 3.24 110 2.61 106 3.10 225 4.51 148 4.44
Q Secondary metabolites biosynthesis, transport and catabolism 20 0.58 23 0.67 19 0.45 16 0.46 32 0.64 28 0.84
R General function prediction only 158 4.61 144 4.21 169 4.01 153 4.47 192 3.84 162 4.86
S Unknown function 60 1.75 56 1.63 68 1.61 70 2.04 90 1.80 72 2.16
Not in COGs 1789 52.23 1747 51.09 2409 57.28 1781 52.09 2777 55.67 1528 45.85

COGs, Clusters of Orthologous Groups database.

a

Total is based on total number of protein-coding genes in annotated genome.

Table 7.

Genome comparison of closely related Bacteroides species.

Organism Strain INSDC Size (Mb) G+C (mol%) Total genes
Bacteroides ilei Marseille-P3208T FQSC00000000 3.97 45.02 3425
Bacteroides mediterraneensis Marseille-P2644T FQRZ00000000 4.07 47.47 3419
Bacteroides coprophilus DSM 18228 ACBW00000000 3.87 45.71 3939
Bacteroides coprocola DSM 17136 ABIY00000000 4.30 41.86 4291
Bacteroides ndongoniae Marseille-P3108T FNVV00000000 4.94 47.67 4205
Bacteroides togonis Marseille-P3166T FQXX00000000 3.97 48.25 3419
Bacteroides congonensis Marseille-P3132T FQXY00000000 6.37 42.96 4988
Bacteroides ihuae Marseille-P2824T FNVX00000000 4.06 39.71 3332
Bacteroides graminisolvens JCM15093 BAJS00000000 3.68 41.5 3403
Bacteroides eggerthii JCM12986 ABVO00000000 4.19 44.6 3488
Bacteroides thetaiotaomicron VPI5482 PUEO00000000 6.29 42.86 4825

INSDC, International Nucleotide Sequence Database Collaboration

Furthermore, digital DNA-DNA hybridization values (Table 8) between compared species except for the studied strains ranged from 17.90% to 34.50%. When the studied strains were compared to other Bacteroides species, the values were approximately in the same range: 19.70–29.80% for strain Marseille-P2644, 18.50–20.40% for strain Marseille-P2824, 18.60–25.60% for strain Marseille-P3132, 19.40–50.00% for strain Marseille-P3108, 17.90–25.70% for strain Marseille-P3166 and 19.40–50.00% for strain Marseille-P3208. This confirms their new Bacteroides species status. These results are supported by values lower than 70%.

Table 8.

Pairwise comparison of Bacteroides species using GGDC, formula 2 (DDH estimates based on identities/HSP length),a upper right

1 2 3 4 5 6 7 8 9 10 11
1 100% 25.60% ± 2.3 29.80% ± 2.4 24.60% ± 2.4 20.20% ± 2.3 25.00% ± 2.4 24.60% ± 2.4 23.40% ± 2.3 22.20% ± 2.3 19.70% ± 2.3 22.80% ± 2.3
2 100% 50.00% ± 2.6 22.80% ± 2.4 19.40% ± 2.3 25.20% ± 2.1 24.10% ± 2.4 24.90% ± 2.4 21.60% ± 2.3 19.70% ± 2.3 29.10% ± 2.4
3 100% 21.70% ± 2.3 19.50% ± 2.2 25.70% ± 2.4 26.00% ± 2.4 31.80% ± 2.5 21.20% ± 2.3 19.40% ± 2.2 24.20% ± 2.3
4 100% 19.10% ± 2.3 21.80% ± 2.3 24.00% ± 2.3 22.00% ± 2.3 25.60% ± 2.4 18.60% ± 2.2 20.70% ± 2.3
5 100% 19.00% ± 2.2 20.40% ± 2.3 18.60% ± 2.2 19.80% ± 2.3 18.50% ± 2.2 19.60% ± 2.3
6 100% 25.70% ± 2.4 24.60% ± 2.4 20.80% ± 2.3 17.90% ± 2.2 22.80% ± 2.4
7 100% 25.00% ± 2.4 23.30% ± 2.3 20.20% ± 2.3 34.50% ± 2.5
8 100% 21.60% ± 2.3 18.80% ± 2.2 22.70% ± 2.3
9 100% 18.50% ± 2.3 22.30% ± 2.3
10 100% 18.60% ± 2.3
11 100%

Bold indicates comparison between strain and itself.

DDH, DNA-DNA hybridization; GGDC, Genome-to-Genome Distance Calculator; HSP, high-scoring segment pairs.

1, B. mediterraneensis; 2, B. ilei; 3, B. ndongoniae; 4, B. congonensis; 5, B. ihuae; 6, B. togonis; 7, B. coprocola; 8, B. coprophilus; 9, B. thetaiotaomicron; 10, B. graminisolvens; 11, B. eggerthii.

a

Confidence intervals indicate inherent uncertainty in estimating DDH values from intergenomic distances based on models derived from empirical test data sets (which are always limited in size).

Conclusion

According to their phylogenetic, phenotypic and biochemical features and genomic comparisons, we propose the creation of six new species as members of the Bacteroides genus: Bacteroides mediterraneensis strain Marseille-P2644, Bacteroides ihuae strain Marseille-P2824, Bacteroides togonis strain Marseille-P3166, Bacteroides ndongoniae strain Marseille-P3108, Bacteroides ilei strain Marseille-P3208 and Bacteroides congonensis strain Marseille-P3132.

Description of Bacteroides ilei sp. nov.

Bacteroides ilei (i'le.i, L. gen. n., ilei, ‘of the ileum,’ the part of the digestive tract from which the bacterium was collected).

Cells are Gram-negative bacilli and have a fusiform shape with a length of 4 to 5 μm and a width of 0.5 to 0.6 μm. The type strain did not exhibit catalase or oxidase activities. Bacteroides ilei is non–spore forming and nonmotile. Colonies are circular, small and translucent with a diameter of 0.8 to 1 mm. Optimum growth occurred in an anaerobic atmosphere at 37°C and pH 7 on Columbia agar enriched with 5% sheep's blood after 7 days of growth. Growth was observed at pH values between 5 to 8 and without NaCl.

Results of the API ZYM strip show that the strain possesses an activity for the following enzymes: alkaline phosphatase, esterase (C4), α-chymotrypsin, acid phosphatase, naphthol-AS-BI-phosphohydrolase, α-galactosidase, β-galactosidase, α-glucosidase, β-glucosidase and α-fucosidase. The other enzymes of the strip have no activities (Supplementary Table S2). Results of the API 50CH strip show that the strain is able to metabolize the following substrates: amygdalin, esculin ferric citrate, glycogen and potassium 5-ketogluconate. The others are negative (Supplementary Table S3). Finally, the results of the API 20A strip show a positive reaction only for β-glucosidase (Supplementary Table S4).

Bacteroides ilei is resistant to gentamicin and susceptible to other tested antibiotics (Table 4).

The major fatty acid is 12-methyl-tetradecanoic acid (47%).

The genome of strain Marseille-P3208 is 3 974 619 bp long with a 45.02 mol% G+C content. In the European Molecular Biology Laboratory–European Bioinformatics Institute (EMBL-EBI) database, the 16S rRNA gene and genome sequences are available under accession numbers LT623890 and FQSC00000000, respectively. The strain Marseille-P3208T is the type strain of the species Bacteroides ilei (= CSUR P3208 = CCUG 69964) and was isolated from the ileum of a 76-year-old woman with oesophagitis in Marseille, France. This bacteria was also found in the left colon of the same patient.

Description of Bacteroides mediterraneensis sp. nov.

Bacteroides mediterraneensis (me.di.ter.ra.ne.en'sis, L. masc. adj., mediterraneensis, ‘of Mediterranea,’ the sea bordering Marseille, where the strain was isolated).

Cells are Gram-negative bacilli and are rod shaped with a length of 0.9 to 2.3 μm and a width of 0.6 to 0.7 μm. The type strain exhibited a catalase activity but no oxidase activity. Bacteroides mediterraneensis is non–spore forming but motile. Colonies are circular, translucent, grey and shiny, with a diameter of 0.6 mm. Optimum growth occurred in an anaerobic atmosphere at 37°C and pH 7 on Columbia agar enriched with 5% sheep's blood after 1 day of growth. Growth was observed at pH values between 5 to 8 and without NaCl.

Results of the API ZYM strip show that the strain possesses an activity for the following enzymes: alkaline phosphatase, esterase (C4), esterase lipase (C8), leucine arylamidase, α-chymotrypsin, acid phosphatase, naphthol-AS-BI-phosphohydrolase, α-galactosidase, β-galactosidase, α-glucosidase, β-glucosidase, N-acetyl-β-glucosaminidase and α-fucosidase. The other enzymes of the strip have no activity (Supplementary Table S2). Results of the API 50CH strip show that the strain is able to metabolize the following substrates: d-arabinose, l-arabinose, d-xylose, d-glucose, methyl-αd-glucopyranoside, N-acetylglucosamine, esculin ferric citrate, salicin, d-cellobiose, d-maltose, d-melibiose, d-saccharose, inulin, d-raffinose, amidon and potassium 5-ketogluconate. The others are negative (Supplementary Table S3). Finally, the results of the API 20A strip show positive reactions for the following: glucose, lactose, saccharose, maltose, salicin, xylose, arabinose, cellobiose, mannose, raffinose and β-glucosidase (Supplementary Table S4).

Bacteroides mediterraneensis was resistant to gentamicin, trimethoprim/sulfamethoxazole, oxacillin and erythromycin and susceptible to other tested antibiotics (Table 4). The major fatty acid is 12-methyl-tetradecanoic acid (39%).

The genome of strain Marseille-P2644 is 4 075 657 bp long with a 47.47 mol% G+C content. In the EMBL-EBI database, the 16S rRNA gene and genome sequences are available under accession numbers LT558804 and FQRZ00000000, respectively. The strain Marseille-P2644T is the type strain of the species Bacteroides mediterraneensis (= CSUR P2644 = DSM 103033) and was isolated from the ileum of a 58-year-old woman undergoing colorectal cancer screening in Marseille, France. This bacterium was also found in the stomach and the right and left colon of the same patient.

Description of Bacteroides ndongoniae sp. nov.

Bacteroides ndongoniae (ndon.go'ni.ae, N.L. fem. gen. n., ndongoniae, ‘of Ndongo,’ the family name of Sokhna Ndongo, a Senegalese microbiologist involved in culturomics and in the description of new bacterial species).

Cells are Gram-negative bacilli and are rod shaped with a length of 2.2 to 3.1 μm and a width of 0.6 to 1.1 μm. The type strain exhibits a catalase activity but no oxidase activity. Bacteroides ndongoniae is non–spore forming and also nonmotile. Colonies are circular, translucent, small and grey, with a diameter of 1 to 1.2 mm. Optimum growth occurred in an anaerobic atmosphere at 37°C and pH 7 on Columbia agar enriched with 5% sheep's blood after 7 days of growth. Growth was observed at pH values between 7 to 7.5 and without NaCl.

Results of the API ZYM strip show that the strain possesses an activity for the following enzymes: alkaline phosphatase, esterase (C4), esterase lipase (C8), leucine arylamidase, acid phosphatase, naphthol-AS-BI-phosphohydrolase, α-galactosidase, β-galactosidase, α-glucosidase, β-glucosidase, N-acetyl-β-glucosaminidase and α-fucosidase. The other enzymes of the strip have no activity (Supplementary Table S2). Results of the API 50CH strip show that the strain is able to metabolize the following substrates: esculin ferric citrate, d-turanose, potassium 5-ketogluconate. The others are negative (Supplementary Table S3). Finally, the results of the API 20A strip show positive reactions for the following: glucose, lactose, saccharose, maltose, xylose, arabinose, cellobiose, mannose, raffinose, rhamnose and β-glucosidase (Supplementary Table S4).

Bacteroides ndongoniae was resistant to clindamycin, gentamicin, trimethoprim/sulfamethoxazole, oxacillin and erythromycin and susceptible to other tested antibiotics (Table 4). The major fatty acid is hexadecanoic acid (26%).

The genome of strain Marseille-P3108 is 4 949 270 bp long with a 47.67 mol% G+C content. In the EMBL-EBI database, the 16S rRNA gene and genome sequences are available under accession numbers LT615364 and FNVV00000000, respectively. The strain Marseille-P3108T is the type strain of the new species Bacteroides ndongoniae (= CSUR P3108 = DSM 103636) and was isolated from the right colon of a 76-year-old woman with oesophagitis in Marseille, France. This bacterium was also found in the left colon of the same patient.

Description of Bacteroides togonis sp. nov.

Bacteroides togonis (to.go'nis, N. L. masc. gen. n., togonis, named in honor of Amadou Togo, a Malian microbiologist involved in culturomics and in the description of new bacterial species).

Cells are Gram-negative bacilli and are rod shaped with a length of 1.4 to 3.2 μm and a width of 0.6 to 0.7 μm. The type strain did not exhibit activities for catalase and oxidase. Bacteroides togonis is non–spore forming but motile. Colonies are small, circular and white, with a diameter of 0.6 to 0.8 mm. Optimum growth occurred in an anaerobic atmosphere at 37°C and pH 7 on Columbia agar enriched with 5% sheep's blood after 3 days of growth. Growth was observed at pH values between 7 to 7.5 and without NaCl.

Results of the API ZYM strip show that the strain possesses activity for the following enzymes: alkaline phosphatase, esterase (C4), esterase lipase (C8), leucine arylamidase, valine arylamidase, cystine arylamidase, acid phosphatase, naphthol-AS-BI-phosphohydrolase, α-galactosidase, β-galactosidase, α-glucosidase, N-acetyl-β-glucosaminidase and α-fucosidase. The other enzymes of the strip had no activity (Supplementary Table S2). Results of the API 50CH strip show that the strain is able to metabolize the following substrates: d-arabinose, N-acetylglucosamine, amygdalin, esculin ferric citrate, d-melibiose, d-melezitose, xylitol, gentiobiose, d-tagatose, potassium gluconate, potassium 5-ketogluconate. The others were negative (Supplementary Table S3). Finally, the results of the API 20A strip show positive reactions for the following: glucose, lactose, saccharose, maltose, xylose, arabinose, mannose, raffinose, rhamnose and β-glucosidase (Supplementary Table S4).

Bacteroides togonis was resistant to amoxicillin, clindamycin, gentamicin, trimethoprim/sulfamethoxazole, oxacillin and erythromycin and susceptible to other tested antibiotics (Table 4). The major fatty acid is 13-methyl-tetradecanoic acid (26%).

The genome of strain Marseille-P3166 is 3 977 096 bp long with a 48.26 mol% G+C content. In the EMBL-EBI database, the 16S rRNA gene and genome sequences are available under accession numbers LT631521 and FQXX00000000, respectively. The strain Marseille-P3166T is the type strain of the species Bacteroides togonis (= CSUR P3166 = DSM 103637) and was isolated from the right colon of a 76-year-old woman with oesophagitis in Marseille, France.

Description of Bacteroides congonensis sp. nov.

Bacteroides congonensis (con.go'ne.n'sis, L. masc. adj., congonensis, ‘from Congo,’ the country where the sample was collected).

Cells are Gram-negative bacilli and are rod shaped with a length of 1 to 1.2 μm and a width of 0.6 to 0.7 μm. The type strain exhibits catalase activity but no oxidase activity. Bacteroides congonensis is non–spore forming and motile. Colonies are smooth, with a diameter of 0.8 to 1 mm. Optimum growth occurred in an anaerobic atmosphere at 37°C and pH 7 on Columbia agar enriched with 5% sheep's blood after 10 days of growth. Growth was observed at pH values between 6 to 8.5 and at a concentration of 50 g/L of NaCl.

Results of the API ZYM strip show that the strain possesses an activity for the following enzymes: alkaline phosphatase, esterase (C4), esterase lipase (C8), leucine arylamidase, acid phosphatase, naphthol-AS-BI-phosphohydrolase, α-galactosidase, β-galactosidase, α-glucosidase, β-glucosidase, N-acetyl-β-glucosaminidase and α-fucosidase. The other enzymes of the strip had no activity (Supplementary Table S2). Results of the API 50CH strip showed that the strain is able to metabolize most of the substrates except: erythritol, l-xylose, d-adonitol, methyl-βd-xylopyranoside, l-sorbose, dulcitol, inositol, d-mannitol, methyl-αd-mannopyranoside, methyl-αd-glucopyranoside, arbutin, salicin, d-trehalose, inulin, d-melezitose, d-turanose, d-lyxose, d-tagatose, d-fucose, d-arabitol, l-arabitol, potassium gluconate and potassium 2-ketogluconate (Supplementary Table S3). Finally, the results of the API 20A strip show positive reactions for all the studied reactions except for the formation of indole, urease, hydrolysis of gelatin and esculin (Supplementary Table S4).

Bacteroides congonensis was susceptible to rifampicin, amoxicillin, imipenem, amoxicillin/clavulanic acid, metronidazole and trimethoprim/sulfamethoxazole and resistant to other tested antibiotics (Table 4). The major fatty acid is 12-methyl-tetradecanoic acid (60%).

The genome of strain Marseille-P3132 is 6 373 337 bp long with a 42.96 mol% G+C content. In the EMBL-EBI database, the 16S rRNA gene and genome sequences are available under accession numbers LT598566 and FQXY00000000, respectively. The strain Marseille-P3132T is the type strain of the species Bacteroides congonensis (= CSUR P3132 = CCUG 70144) and was isolated from the stool of a 35-year-old healthy pygmy woman in Congo.

Description of Bacteroides ihuae sp. nov.

Bacteroides ihuae (i.hu'ae, N. L. gen. n., ihuae, ‘of IHU’ (Institut Hospitalo-Universitaire), where the type strain was cultivated).

Cells are Gram-negative bacilli and are rod shaped with a length of 1 to 1.6 μm and a width of 0.5 to 0.6 μm. The type strain does not exhibit activities for catalase or oxidase. B. ihuae is non–spore forming and motile. Colonies are mucous, with a diameter of 1 to 3 mm. Optimum growth occurred in an anaerobic atmosphere at 30°C and pH 7 on Columbia agar enriched with 5% sheep's blood after 10 days of growth. Growth was observed at pH values between 6 to 8.5 and at a concentration of 5g/l of NaCl.

Results of the API ZYM strip show that the strain possesses an activity for the following enzymes: alkaline phosphatase, esterase (C4), esterase lipase (C8), acid phosphatase, naphthol-AS-BI-phosphohydrolase, α-galactosidase, β-galactosidase, α-glucosidase, β-glucosidase and N-acetyl-β-glucosaminidase. The other enzymes of the strip had no activity (Supplementary Table S2). Results of the API 50CH strip show that the strain is able to metabolize most of the substrates except: erythritol, d-arabinose, l-xylose, d-adonitol, methyl-βd-xylopyranoside, l-sorbose, dulcitol, inositol, methyl-αd-mannopyranoside, d-melezitose, d-lyxose, d-fucose, l-fucose, d-arabitol, l-arabitol, potassium gluconate, potassium 2-ketogluconate and potassium 5-ketogluconate (Supplementary Table S3). Finally, the results of the API 20A strip show positive reactions for all studied reactions except for indole formation, urease, mannitol, hydrolysis of gelatin, glycerol, melezitose, sorbitol and rhamnose (Supplementary Table S4).

B. ihuae was resistant to gentamicin, oxacillin, fosfomycin and ceftriaxone and susceptible to others tested antibiotics (Table 4). The major fatty acid is 12-methyl-tetradecanoic acid (47%).

The genome of strain Marseille-P2824 is 4 063 701 bp long with a 39.71 mol% G+C content. In the EMBL-EBI database, the 16S rRNA gene and genome sequences are available under accession numbers LT576386 and FNVX00000000, respectively. The strain Marseille-P2824T is the type strain of the species Bacteroides ihuae (= CSUR P2824 = CCUG 70550) was isolated from the sputum of a healthy 27-year-old woman in Marseille, France.

Acknowledgements

The authors thank the Xegen Company (http://www.xegen.fr/) for automating the genomic annotation process. We thank M. Lardière for English-language editorial work, A. Caputo for submitting the genomic sequences to GenBank and A. Oren for providing etymology corrections.

This study was funded by the Fondation Méditerranée Infection. This work was also supported by the French government under the ‘Investissements d'avenir’ program managed by the Agence Nationale de la Recherche (Méditerranée Infection 10-IAHU-03).

Footnotes

Appendix A

Supplementary data related to this article can be found at https://doi.org/10.1016/j.nmni.2018.06.006.

Conflict of interest

None declared.

Appendix A. Supplementary data

The following are the supplementary data related to this article:

Multimedia component 1
mmc1.pdf (486KB, pdf)

References

  • 1.Castellani A., Chalmers A.J. 3rd ed. Williams Wood; New York: 1919. Manual of tropical medicine. [Google Scholar]
  • 2.Veillon A., Zuber A. Recherches sur quelques microbes strictement anaérobies et leur rôle en pathologie. In: Masson G., editor. vol. 10. 1898. pp. 517–545. (Archives de médecine expérimentale et d’anatomie pathologique). Paris. [Google Scholar]
  • 3.Wexler H.M. Bacteroides: the good, the bad, and the nitty-gritty. Clin Microbiol Rev. 2007;20:593–621. doi: 10.1128/CMR.00008-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Akin H., Tözün N. Diet, microbiota, and colorectal cancer. J Clin Gastroenterol. 2014;48:S67–S69. doi: 10.1097/MCG.0000000000000252. [DOI] [PubMed] [Google Scholar]
  • 5.Gagnière J., Raisch J., Veziant J., Barnich N., Bonnet R., Buc E. Gut microbiota imbalance and colorectal cancer. World J Gastroenterol. 2016;22:501–518. doi: 10.3748/wjg.v22.i2.501. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Lagier J.C., Armougom F., Million M., Hugon P., Pagnier I., Robert C. Microbial culturomics: paradigm shift in the human gut microbiome study. Clin Microbiol Infect. 2012;18:1185–1193. doi: 10.1111/1469-0691.12023. [DOI] [PubMed] [Google Scholar]
  • 7.Lagier J.C., Hugon P., Khelaifia S., Fournier P.E., La Scola B., Raoult D. The rebirth of culture in microbiology through the example of culturomics to study human gut microbiota. Clin Microbiol Rev. 2015;28:237–264. doi: 10.1128/CMR.00014-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Lagier J.C., Khelaifia S., Alou M.T., Ndongo S., Dione N., Hugon P. Culture of previously uncultured members of the human gut microbiota by culturomics. Nat Microbiol. 2016;1:16203. doi: 10.1038/nmicrobiol.2016.203. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
  • 9.Lagier J.C., Edouard S., Pagnier I., Mediannikov O., Drancourt M., Raoult D. Current and past strategies for bacterial culture in clinical microbiology. Clin Microbiol Rev. 2015;28:208–236. doi: 10.1128/CMR.00110-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Fournier P.E., Lagier J.C., Dubourg G., Raoult D. From culturomics to taxonomogenomics: a need to change the taxonomy of prokaryotes in clinical microbiology. Anaerobe. 2015;36:73–78. doi: 10.1016/j.anaerobe.2015.10.011. [DOI] [PubMed] [Google Scholar]
  • 11.Ramasamy D., Mishra A.K., Lagier J.C., Padhmanabhan R., Rossi M., Sentausa E. A polyphasic strategy incorporating genomic data for the taxonomic description of novel bacterial species. Int J Syst Evol Microbiol. 2014;64:384–391. doi: 10.1099/ijs.0.057091-0. [DOI] [PubMed] [Google Scholar]
  • 12.Seng P., Drancourt M., Gouriet F., La Scola B., Fournier P.E., Rolain J.M. Ongoing revolution in bacteriology: routine identification of bacteria by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Clin Infect Dis. 2009;49:543–551. doi: 10.1086/600885. [DOI] [PubMed] [Google Scholar]
  • 13.Dubourg G., Cimmino T., Senkar S.A., Lagier J.C., Robert C., Flaudrops C. Noncontiguous finished genome sequence and description of Paenibacillus antibioticophila sp. nov. GD11(T), the type strain of Paenibacillus antibioticophila. New Microbe New Infect. 2015;8:137–147. doi: 10.1016/j.nmni.2015.10.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Morel A.S., Dubourg G., Prudent E., Edouard S., Gouriet F., Casalta J.P. Complementarity between targeted real-time specific PCR and conventional broad-range 16S rDNA PCR in the syndrome-driven diagnosis of infectious diseases. Eur J Clin Microbiol Infect Dis. 2015;34:561–570. doi: 10.1007/s10096-014-2263-z. [DOI] [PubMed] [Google Scholar]
  • 15.Drancourt M., Bollet C., Carlioz A., Martelin R., Gayral J.P., Raoult D. 16S ribosomal DNA sequence analysis of a large collection of environmental and clinical unidentifiable bacterial isolates. J Clin Microbiol. 2000;38:3623–3630. doi: 10.1128/jcm.38.10.3623-3630.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Kim M., Oh H.S., Park S.C., Chun J. Towards a taxonomic coherence between average nucleotide identity and 16S rRNA gene sequence similarity for species demarcation of prokaryotes. Int J Syst Evol Microbiol. 2014;64:346–351. doi: 10.1099/ijs.0.059774-0. [DOI] [PubMed] [Google Scholar]
  • 17.Sasser M. Microbial ID; Newark, NY: 2006. Bacterial identification by gas chromatographic analysis of fatty acids methyl esters (GC-FAME) [Google Scholar]
  • 18.Dione N., Sankar S.A., Lagier J.C., Khelaifia S., Michele C., Armstrong N. Genome sequence and description of Anaerosalibacter massiliensis sp. nov. New Microbe New Infect. 2016;10:66–76. doi: 10.1016/j.nmni.2016.01.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Matuschek E., Brown D.F., Kahlmeter G. Development of the EUCAST disk diffusion antimicrobial susceptibility testing method and its implementation in routine microbiology laboratories. Clin Microbiol Infect. 2014;20:O255–O266. doi: 10.1111/1469-0691.12373. [DOI] [PubMed] [Google Scholar]
  • 20.Zerbino D.R., Birney E. Velvet: algorithms for de novo short read assembly using de Bruijn graphs. Genome Res. 2008;18:821–829. doi: 10.1101/gr.074492.107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Bankevich A., Nurk S., Antipov D., Gurevich A.A., Dvorkin M., Kulikov A.S. SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing. J Comput Biol. 2012;19:455–477. doi: 10.1089/cmb.2012.0021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Luo R., Liu B., Xie Y., Li Z., Huang W., Yuan J. SOAPdenovo2: an empirically improved memory-efficient short-read de novo assembler. GigaScience. 2012;1:18. doi: 10.1186/2047-217X-1-18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Bolger A.M., Lohse M., Usadel B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics. 2014;30:2114–2120. doi: 10.1093/bioinformatics/btu170. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Hyatt D., Chen G.L., Locascio P.F., Land M.L., Larimer F.W., Hauser L.J. Prodigal: prokaryotic gene recognition and translation initiation site identification. BMC Bioinform. 2010;11:119. doi: 10.1186/1471-2105-11-119. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Lowe T.M., Eddy S.R. tRNAscan-SE: a program for improved detection of transfer RNA genes in genomic sequence. Nucleic Acids Res. 1997;25:955–964. doi: 10.1093/nar/25.5.955. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Lagesen K., Hallin P., Rodland E.A., Staerfeldt H.H., Rognes T., Ussery D.W. RNAmmer: consistent and rapid annotation of ribosomal RNA genes. Nucleic Acids Res. 2007;35:3100–3108. doi: 10.1093/nar/gkm160. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Käll L., Krogh A., Sonnhammer E.L. A combined transmembrane topology and signal peptide prediction method. J Mol Biol. 2004;338:1027–1036. doi: 10.1016/j.jmb.2004.03.016. [DOI] [PubMed] [Google Scholar]
  • 28.Eddy S.R. Accelerated profile HMM searches. PLoS Comput Biol. 2011;7 doi: 10.1371/journal.pcbi.1002195. e1002195. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Conway K.R., Boddy C.N. ClusterMine360: a database of microbial PKS/NRPS biosynthesis. Nucleic Acids Res. 2013;41:D402–D407. doi: 10.1093/nar/gks993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Gupta S.K., Padmanabhan B.R., Diene S.M., Lopez-Rojas R., Kempf M., Landraud L., Rolain J.M. ARG-ANNOT, a new bioinformatic tool to discover antibiotic resistance genes in bacterial genomes. Antimicrob Agents Chemother. 2014;58:212–220. doi: 10.1128/AAC.01310-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Gouret P., Paganini J., Dainat J., Louati D., Darbo E., Pontarotti P. Integration of evolutionary biology concepts for functional annotation and automation of complex research in evolution: the multi-agent software system DAGOBAH. In: Pontarotti P., editor. Evolutionary biology—concepts, biodiversity, macroevolution and genome evolution. Springer; Berlin: 2011. pp. 71–87. [Google Scholar]
  • 32.Gouret P., Vitiello V., Balandraud N., Gilles A., Pontarotti P., Danchin E.G. FIGENIX: intelligent automation of genomic annotation: expertise integration in a new software platform. BMC Bioinform. 2005;6:198. doi: 10.1186/1471-2105-6-198. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Lechner M., Findeib S., Steiner L., Marz M., Stadler P.F., Prohaska S.J. Proteinortho: detection of (co-)orthologs in large-scale analysis. BMC Bioinform. 2011;12:124. doi: 10.1186/1471-2105-12-124. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Gouret P., Thompson J.D., Pontarotti P. PhyloPattern: regular expressions to identify complex patterns in phylogenetic trees. BMC Bioinform. 2009;10:298. doi: 10.1186/1471-2105-10-298. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Rossi-Tamisier M., Benamar S., Raoult D., Fournier P.E. Cautionary tale of using 16S rRNA gene sequence similarity values in identification of human-associated bacterial species. Int J Syst Evol Microbiol. 2015;65:1929–1934. doi: 10.1099/ijs.0.000161. [DOI] [PubMed] [Google Scholar]
  • 36.Nishiyama T., Ueki A., Kaku N., Watanabe K., Ueki K. Bacteroides graminisolvens sp. nov., a xylanolytic anaerobe isolated from a methanogenic reactor treating cattle waste. Int J Syst Evol Microbiol. 2009;59:1901–1907. doi: 10.1099/ijs.0.008268-0. [DOI] [PubMed] [Google Scholar]
  • 37.Bakir M.A., Kitahara M., Sakamoto M., Matsumoto M., Benno Y. Bacteroides finegoldii sp. nov., isolated from human faeces. Int J Syst Evol Microbiol. 2006;56:931–935. doi: 10.1099/ijs.0.64084-0. [DOI] [PubMed] [Google Scholar]
  • 38.Kitahara M., Sakamoto M., Ike M., Sakata S., Benno Y. Bacteroides plebeius sp. nov. and Bacteroides coprocola sp. nov., isolated from human faeces. Int J Syst Evol Microbiol. 2005;55:2143–2147. doi: 10.1099/ijs.0.63788-0. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Multimedia component 1
mmc1.pdf (486KB, pdf)

Articles from New Microbes and New Infections are provided here courtesy of Elsevier

RESOURCES